Long-acting injectable antipsychotics treatment during COVID-19 pandemic – A new challenge

Detalles Bibliográficos
Autores principales: Ifteni, Petru, Dima, Lorena, Teodorescu, Andreea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185008/
https://www.ncbi.nlm.nih.gov/pubmed/32349886
http://dx.doi.org/10.1016/j.schres.2020.04.030
_version_ 1783526684183494656
author Ifteni, Petru
Dima, Lorena
Teodorescu, Andreea
author_facet Ifteni, Petru
Dima, Lorena
Teodorescu, Andreea
author_sort Ifteni, Petru
collection PubMed
description
format Online
Article
Text
id pubmed-7185008
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71850082020-04-27 Long-acting injectable antipsychotics treatment during COVID-19 pandemic – A new challenge Ifteni, Petru Dima, Lorena Teodorescu, Andreea Schizophr Res Letter to the Editor Elsevier B.V. 2020-06 2020-04-27 /pmc/articles/PMC7185008/ /pubmed/32349886 http://dx.doi.org/10.1016/j.schres.2020.04.030 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Ifteni, Petru
Dima, Lorena
Teodorescu, Andreea
Long-acting injectable antipsychotics treatment during COVID-19 pandemic – A new challenge
title Long-acting injectable antipsychotics treatment during COVID-19 pandemic – A new challenge
title_full Long-acting injectable antipsychotics treatment during COVID-19 pandemic – A new challenge
title_fullStr Long-acting injectable antipsychotics treatment during COVID-19 pandemic – A new challenge
title_full_unstemmed Long-acting injectable antipsychotics treatment during COVID-19 pandemic – A new challenge
title_short Long-acting injectable antipsychotics treatment during COVID-19 pandemic – A new challenge
title_sort long-acting injectable antipsychotics treatment during covid-19 pandemic – a new challenge
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185008/
https://www.ncbi.nlm.nih.gov/pubmed/32349886
http://dx.doi.org/10.1016/j.schres.2020.04.030
work_keys_str_mv AT iftenipetru longactinginjectableantipsychoticstreatmentduringcovid19pandemicanewchallenge
AT dimalorena longactinginjectableantipsychoticstreatmentduringcovid19pandemicanewchallenge
AT teodorescuandreea longactinginjectableantipsychoticstreatmentduringcovid19pandemicanewchallenge

Ejemplares similares